PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

NCT06430736 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Myeloma
Lymphoma
Leukemia

Interventions

DRUG: Tocilizumab before CAR-T cell infusion
DRUG: Tocilizumab at emerging CRS

Sponsor

Insel Gruppe AG, University Hospital Bern